Subgroup differences in 'brain-type' transferrin and α-synuclein in Parkinson's disease and multiple system atrophy

Area of Science:

• Neuroscience
• Biochemistry
• Metabolomics

Background:

• Two transferrin (Tf) glycan-isoforms, Tf-1 (choroid plexus origin) and Tf-2 (serum origin), exist in cerebrospinal fluid (CSF).
• The ratio of these isoforms (Tf-2/Tf-1) defines the Tf index, reflecting metabolic differences.

Purpose of the Study:

• To investigate metabolic differences in CSF transferrin isoforms across neurological disorders.
• To determine if the Tf index can differentiate between tauopathies, Parkinson's disease (PD), multiple system atrophy (MSA), and controls.

Main Methods:

• Calculation of the Tf index (Tf-2/Tf-1 ratio) in CSF samples.
• Comparison of Tf indices between patient groups (Alzheimer's disease, PD, MSA) and neurological controls.
• Analysis of CSF alpha-synuclein levels in PD patients and subgroup identification using quantile-quantile plots.

Main Results:

• Tf indices were similar in Alzheimer's disease patients and controls (P = 0.147).
• PD and MSA patients exhibited significantly higher Tf indices compared to controls (P < 0.001 and P = 0.024, respectively).
• A subgroup within PD and MSA showed elevated Tf indices, with PD subgroups also displaying higher CSF alpha-synuclein levels (P = 0.012).

Conclusions:

• The Tf index may help distinguish PD and MSA from tauopathies and controls.
• PD and MSA appear to comprise distinct subgroups with differing CSF transferrin and alpha-synuclein metabolism.
• These findings suggest potential for novel diagnostic or prognostic biomarkers in neurodegenerative diseases.